BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 33095968)

  • 21. Determination of urinary metabolites of cannabidiol, Δ
    Sim YE; Kim JW; Ko BJ; Kim JY; Cheong JC; Pyo J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123568. PubMed ID: 36527808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative determination of five cannabinoids in blood and urine by gas chromatography tandem mass spectrometry applying automated on-line solid phase extraction.
    Frei P; Frauchiger S; Scheurer E; Mercer-Chalmers-Bender K
    Drug Test Anal; 2022 Jul; 14(7):1223-1233. PubMed ID: 35187817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orally administered cannabidiol does not produce false-positive tests for Δ
    McCartney D; Kevin RC; Suraev AS; Irwin C; Grunstein RR; Hoyos CM; McGregor IS
    Drug Test Anal; 2022 Jan; 14(1):137-143. PubMed ID: 34412166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma.
    Karschner EL; Barnes AJ; Lowe RH; Scheidweiler KB; Huestis MA
    Anal Bioanal Chem; 2010 May; 397(2):603-11. PubMed ID: 20306180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a simple and sensitive HPLC-UV method for the simultaneous determination of cannabidiol and Δ(9)-tetrahydrocannabinol in rat plasma.
    Zgair A; Wong JC; Sabri A; Fischer PM; Barrett DA; Constantinescu CS; Gershkovich P
    J Pharm Biomed Anal; 2015 Oct; 114():145-51. PubMed ID: 26048666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".
    Pacifici R; Pichini S; Pellegrini M; Rotolo MC; Giorgetti R; Tagliabracci A; Busardò FP; Huestis MA
    Clin Chem Lab Med; 2020 Apr; 58(5):682-689. PubMed ID: 30956228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History.
    Berl V; Hurd YL; Lipshutz BH; Roggen M; Mathur EJ; Evans M
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):777-789. PubMed ID: 35787693
    [No Abstract]   [Full Text] [Related]  

  • 28. Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant.
    Ravula A; Chandasana H; Setlow B; Febo M; Bruijnzeel AW; Derendorf H
    J Pharm Biomed Anal; 2018 Oct; 160():119-125. PubMed ID: 30077950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
    J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Ultrafast Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry Method for Cannabidiol Monitoring in Pediatric Refractory Epilepsy.
    Pérez Montilla CA; Schaiquevich PS; Cáceres Guido P; Caraballo RH; Reyes Valenzuela G; Cruz CV; García Bournissen F
    Ther Drug Monit; 2021 Oct; 43(5):712-717. PubMed ID: 33346629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra-high performance liquid chromatography tandem mass-spectrometry for simple and simultaneous quantification of cannabinoids.
    Jamwal R; Topletz AR; Ramratnam B; Akhlaghi F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():10-18. PubMed ID: 28192758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of in utero cannabis exposure by umbilical cord analysis.
    Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
    Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Δ
    Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
    Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
    Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
    JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid chromatography-high resolution mass spectrometry for the determination of three cannabinoids, two (-)-trans-Δ
    Shin Y; Kim JY; Cheong JC; Kim JH; Kim JH; Lee HS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jul; 1149():122157. PubMed ID: 32447253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of Δ8-THC, Δ9-THC, Cannabidiol and 10 Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS-MS.
    Lin L; Amaratunga P; Reed J; Huang P; Lemberg BL; Lemberg D
    J Anal Toxicol; 2022 Feb; 46(1):76-88. PubMed ID: 33270860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of UV and MS/MS detection for the LC analysis of cannabidiol-rich products.
    Nemeškalová A; Hájková K; Mikulů L; Sýkora D; Kuchař M
    Talanta; 2020 Nov; 219():121250. PubMed ID: 32887141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabidiol (CBD) product contamination: Quantitative analysis of Δ
    Johnson E; Kilgore M; Babalonis S
    Drug Alcohol Depend; 2022 Aug; 237():109522. PubMed ID: 35690015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens.
    Vikingsson S; Winecker RE; Cone EJ; Kuntz DJ; Dorsey B; Jacques M; Senter M; Flegel RR; Hayes ED
    J Anal Toxicol; 2022 Oct; 46(8):866-874. PubMed ID: 35260906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-Nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) during Sample Preparation for GC-MS Analysis.
    Hart ED; Vikingsson S; Mitchell JM; Winecker RE; Flegel R; Hayes ED
    J Anal Toxicol; 2022 May; 46(5):573-576. PubMed ID: 33987675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.